HomeTagsHealth

health

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

Tianjin Pharmaceutical Da Ren Tang Is Shrinking To Succeed In FY2025

How TJ DRT’s 33% Revenue "Loss" Fueled a 72% Margin Miracle and a Record...
SGX-LISTED COMPANIES

The Strategy Keeping Camsing Healthcare Alive – FY2026

The Survival Pivot: 4 Lessons from a Retail Healthcare Turnaround Introduction: The narrative of the legacy...
SGX-LISTED COMPANIES

Why China Medical Systems FY2025 Profits Dropped Despite Growth

https://open.spotify.com/episode/3YAldvdzS4eXE4RzkN9M18?si=8a54594510534cfe 5 Game-Changing Takeaways from CMS’s 2025 Transformation For the Chinese pharmaceutical sector, 2025 was the...
SGX-LISTED COMPANIES

How Raffles Medical Is Trading Episodic Care For Longevity Science In FY2025

Introduction: A Half-Century of Evolution As Raffles Medical Group (RMG) marks its 50th anniversary, it...
SGX-LISTED COMPANIES

iX Biopharma’s Secret Shortcut To The US Medical Market – 1H FY2026

From Cash Burn to Bioavailability: How iX Biopharma Slashed Losses by 67% via a...
SGX-LISTED COMPANIES

From Superfoods To Senior Care – Autagco Q1 FY2026

The High-Stakes Gamble of a Singapore Mainstay Introduction: The "Pivot or Perish" Reality In the unforgiving...
SGX-LISTED COMPANIES

Is Camsing Healthcare In Survival Mode? The Truth Behind Their Q3 FY2026

On the Brink of Collapse: 3 Surprising Truths Buried in Camsing Healthcare's Latest Report 1....
SGX-LISTED COMPANIES

One Asset Deal Changed Everything For Tianjin Da Ren Tang In Q3 2025

How Tianjin Da Ren Tang's Revenue Fell 35% While Its Profits Soared: 4 Surprising...
SGX-LISTED COMPANIES

Singapore Paincare Swings To Net Loss In FY2025

5 Surprising Reasons Behind Singapore Paincare's Shocking Swing from Profit to a S$3.7 Million...
SGX-LISTED COMPANIES

Find Out Why ISEC Healthcare’s Strong Q3 2025 Sales Didn’t Translate To Higher Profits

More Sales, Less Profit: 5 Surprising Takeaways from ISEC Healthcare's Latest Financials It’s a fundamental...
SGX-LISTED COMPANIES

Camsing Healthcare Second Quarter 2026 Results

Camsing Healthcare Limited's latest financial results show a mixed performance amid tough economic conditions....
SGX-LISTED COMPANIES

Thomson Medical Group’s FY2025: Strategic Growth and Johor Bay Development

Thomson Medical Group's recent financial period reflects a deliberate investment strategy for future growth,...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...